Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Treatment of Paget's disease of bone.

Lojo Oliveira L, Torrijos Eslava A.

Reumatol Clin. 2012 Jul-Aug;8(4):220-4. doi: 10.1016/j.reuma.2011.06.003. Review. English, Spanish.

2.

[Paget's disease of the bones: diagnosis and treatment].

Jacobs JW, Huisman AM, van Paassen HC, Bijlsma JW.

Ned Tijdschr Geneeskd. 1999 Apr 3;143(14):719-25. Review. Dutch.

PMID:
10347626
3.

[Diagnosis and management of Paget's disease of bone].

Hashimoto J, Yoshikawa H.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:56-64. Review. Japanese. No abstract available.

PMID:
18161082
4.

[Paget's disease and hypercalcemia: coincidence or causal relationship?].

Green I, Altman A.

Harefuah. 2009 Oct;148(10):708-10, 733. Hebrew.

PMID:
20073401
5.

Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.

Alvarez L, Peris P, Guañabens N, Vidal S, Quintó L, Monegal A, Pons F, Ballesta AM, Muñoz-Gómez J.

Rheumatology (Oxford). 2004 Jul;43(7):869-74.

6.

Management of Paget's disease of bone.

Langston AL, Ralston SH.

Rheumatology (Oxford). 2004 Aug;43(8):955-9. Review.

7.

Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.

Alexandersen P, Peris P, Guañabens N, Byrjalsen I, Alvarez L, Solberg H, Cloos PA.

J Bone Miner Res. 2005 Apr;20(4):588-95.

8.

[Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].

Wilczek H.

Cas Lek Cesk. 1997 Dec 3;136(23):730-2. Czech.

PMID:
9476376
9.

Tumor-associated Hypercalcemia in a patient with Paget's disease.

Hung HC, Ou HY, Huang JS, Chuang MC, Wu TJ.

Kaohsiung J Med Sci. 2008 Mar;24(3):152-6. doi: 10.1016/S1607-551X(08)70143-8.

10.

Prediction and assessment of the response of Paget's disease to bisphosphonate treatment.

Hosking DJ.

Bone. 1999 May;24(5 Suppl):69S-71S. Review.

PMID:
10321933
11.

[Osteitis deformans--Paget's disease].

Sieghart S.

Wien Med Wochenschr. 2004;154(5-6):97-101. Review. German.

PMID:
15106891
12.

[Neurological complications of Paget's disease of bone].

Foidart M, Reginster JY, Franchimont P.

Rev Med Liege. 1989 Jun 1;44(11):396-401. Review. French. No abstract available.

PMID:
2664967
13.

Monostotic Paget's disease of the tibia in Korea.

Lee CH, Han SH, Yoon BY, Lee YW.

Clin Rheumatol. 2004 Aug;23(4):381-2.

PMID:
15293109
14.

Medical management of Paget's disease of bone: indications for treatment and review of current therapies.

Siris ES, Lyles KW, Singer FR, Meunier PJ.

J Bone Miner Res. 2006 Dec;21 Suppl 2:P94-8. Review.

15.

Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate.

de la Piedra C, Rapado A, Díaz Diego EM, Díaz Martín MA, Aguirre C, López Gavilanes E, Díaz Curiel M.

Calcif Tissue Int. 1996 Aug;59(2):95-9.

PMID:
8687976
16.

Treatment of patients with Paget's disease of bone.

Roux C, Dougados M.

Drugs. 1999 Nov;58(5):823-30. Review.

PMID:
10595863
17.

[Clinical aspects and therapy of Paget's disease (osteitis deformans)].

Ringe JD.

Dtsch Med Wochenschr. 1983 Aug 5;108(31-32):1207-12. German. No abstract available.

PMID:
6223799
18.
19.

The diagnosis of Paget's disease.

Pande I.

Practitioner. 2001 Sep;245(1626):730-5. Review. No abstract available.

PMID:
11584586
20.

Paget's disease of bone--clinical evaluation and treatment with diphosphonate.

Ibbertson HK, Henley JW, Fraser TR, Tait B, Stephens EJ, Scott DJ.

Aust N Z J Med. 1979 Feb;9(1):31-5. No abstract available.

PMID:
378209
Items per page

Supplemental Content

Support Center